Quotient Sciences team accepting 2025 CDMO Leadership Award

#ICYMI: Quotient Sciences has been recognized as a 2025 #CDMOLeadershipAwards winner in the category of Small Molecule Dosage Form – Global. These awards recognize the best contract development and manufacturing organizations across global and regional categories. bit.ly/4kjcP5I

Quotient Sciences team accepting 2025 CDMO Leadership Award in New York.

Yesterday, our team attended the #CDMOLeadershipAwards in NYC. #QuotientSciences has been named a winner in the Small Molecule Dosage Form - Global category. This is a testament to our dedication to providing innovative, quality services while accelerating #drugdevelopment timelines. bit.ly/4kjcP5I

Quotient Sciences News Quotient Sciences Recognized as a Finalist for Special Category Award in the 2025 CDMO Leadership Awards

We have been named a finalist for a special category award, Best Innovative Approach to Technology and Process Execution, in the 2025 #CDMOLeadershipAwards, highlighting our commitment to providing innovative solutions and exceptional #CDMO services. Stay tuned for more announcements. bit.ly/4kxw37Z

We are proud to announce that Outsourced Pharma has honored us with their 14th Annual #CDMOLeadershipAwards! Determined by customers who utilize cell and gene delivery services, this award recognizes us as their most valued partners. 🤝